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Tumor of cortical epithelial cells of the thymus: types AB, B1 and B2. 
> 50 years old 
Men=Women 
<50 years old 
> Women 
Muscles afected in MG 
Autoreactive T cells are able to move to the periphery and be functional 
Changes  in the thymus caused by thymoma: 
-Medullary area reduced compared to cortical area (imbalance in the cell 
density) 
-Low expression of AIRE (defect in negative selection) 
-High number of immature T cells (CD4 + and CD8 +, DP) 
-High proliferation of cortical thymocytes increases genetic mutations 
-Reduced number of dendritic cells (defect in negative selection) 
-MHCII deficiency (defect in positive selection) 
-FoxP3 deficiency (deregulation of Treg) 
-Treg deficiency (increases survival of autoreactive T cells in the periphery) 
-High levels of expression of type I interferons 
AChR-MG 
Many germinal centers (GCs) are formed in the thymus.  
Changes in the thymus caused by thymic follicular hyperplasia: 
-Thymus overexpression of proinflammatory cytokines  and genes induced by IFN-g 
-Abnormal cytokine network that alters the balance between Th1, Th2 and Th17 
-Defect in Treg (increases survival of autoreactive T cells in the periphery) 
-Reduced number of dendritic cells (defect in negative selection) 
-Low expression of AIRE (defect in negative selection) 
-High expression of TNF-a (chronic inflammation in thymus) 
-Expansion of perivascular spaces, displacement of mioid cells 
-The complement  proteins and autoreactive T cells against AChR attacks mioid 
marrow cells 
-High expression of Bcl-2 prevent apoptosis of autoreactive cells 
 
Increasing antibody production  
Formation of 
GCs 
Recruitment of B 
cells and dendritic 
cells 
Altearing the thymus function 
Antibody-producing cells could 
be exported to the periphery 
-Thymoma:  
Eliminates the production site of  
autoreactive T cells 
-Thymyc follicular hyperplasia: 
Eliminates the production site of 
antibodies anti-ACHR 
The removal of the thymus. 
Only for 
AChR-MG 
patients 
-Thymoma:  
Autoreactive T cells that were exported 
to periphery could be still funcional 
- Thymyc follicular hyperplasia: 
Plasma cells and/or memory cells that 
were exported to periphery still 
produce antibodies anti-AChR 
More studies are needed 
• The function of the thymus is to establish 
tolerance to self antigens.  
• In a normal thymus there is more 
production of autoreactive T cells against 
ACHR than against other antigens.  
• Structural and functional changes in the 
thymus are associated with the AChR-
MG. 
THYMOMA 
AChR-MG 
THYMYC FOLLICULAR 
HYPERPLASIA 
Localisation of the 
thymus 
Thymus 
• Myasthenia Gravis (MG) is an 
autoimmune disease (AID) that 
causes muscle weakness and fatigue. 
It especially affects the ocular, facial 
and bulbar muscles. 
• MG is caused by the production of 
antibodies against proteins of the 
neuromuscular junction:  
LRP4 
IgG MuSK 
AChR  
Introduction 
AChR structure 
OBJECTIVE: TO REVIEW THE CURRENT LITERATURE ON THE ROLE OF THE THYMUS IN MG 
The methodology is based on reading and understanding bibliographical references and the 
subsequent drafting of the report on summarizing and linking all the information of interest. 
 
Conclusions 
• Thymus plays a very important role in the ACHR-MG 
• Thymoma affects the proper functioning of the thymus and favors the 
generation and the exportation of autoreactive T cells to periphery. 
• The presence of GCs in the thymus increases antibody production, 
favours the exportation of antibody-producing cells to periphery and 
alters the thymus function. 
• There is evidence that thymectomy is useful in some cases but not fully 
effective in others. 
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 Acetylcholine Receptor 
 Muscle Specific Kinase 
 Low-density lipoprotein receptor-related protein 
